Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
J&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde…
Read moreDiscover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR …
Read moreSwitzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an…
Read moreFrench government’s ambitious plan to save €1 billion in healthcare expenses by 2024 through new r…
Read moreLearn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial …
Read moreIn a ground breaking move, the international collaboration among six prominent health technology ass…
Read moreThis article explores the new EU pharmaceutical package and criteria of high unmet medical need (HUM…
Read moreThis article explores the significant disparities between the US and Europe regarding orphan drugs a…
Read moreThe Centers for Medicare and Medicaid Services has unveiled a list of 10 drugs to undergo Medicare p…
Read moreMEAs resulted in 195.2 million of savings for the Italian healthcare system, according to AIFA’s M…
Read more